Location History:
- Alan, ME (US) (2006)
- Wellesley, MA (US) (2005 - 2007)
Company Filing History:
3 out of 1,386 
3 out of 517 
Years Active: 2005-2007
Title: Michael J Preston: Innovator in Monoclonal Antibody Research
Introduction
Michael J Preston is a notable inventor based in Wellesley, MA (US), recognized for his contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of three patents to his name, Preston has made significant strides in the diagnosis and treatment of various disorders, including cystic fibrosis.
Latest Patents
Among his latest patents, Preston has developed peptides that specifically bind to mucoid exopolysaccharide. These inventions provide methods for utilizing these peptides in the diagnosis, prophylaxis, and therapy of infections and related disorders. Notably, some of the antibodies enhance opsonophagocytic killing of multiple mucoid strains. The patents also include compositions of these peptides, including pharmaceutical formulations, as well as functionally equivalent variants.
Career Highlights
Throughout his career, Michael J Preston has worked with prestigious institutions such as Brigham and Women's Hospital and Beth Israel Deaconess Medical Center. His work has significantly impacted the field of medical research, particularly in the development of therapeutic solutions for complex diseases.
Collaborations
Preston has collaborated with esteemed colleagues, including Gerald B Pier and Lisa Cavacini, contributing to a rich environment of innovation and research.
Conclusion
Michael J Preston's work in monoclonal antibody research exemplifies the importance of innovation in addressing medical challenges. His patents and collaborations continue to pave the way for advancements in therapeutic applications.